Health Risks Certain women may face increased risks with hormonal contraception, particularly those with a history of blood clots, heart disease, or certain types of cancer
SELECT trial NEJM 2023 n = 17,604 The only GLP-1 with a FDA cardiovascular label If you have established cardiovascular disease and are not diabetic, Wegovy is the only GLP-1 agonist on the market whose label explicitly includes reducing the risk of a heart attack, stroke or cardiovascular death
Over the past ten years, GLP-1 receptor agonists (GLP-1RAs) such as Ozempic, Wegovy, and Mounjaro have taken the pharmaceutical world by storm
This pudding keeps well, so its easy to save the rest for later if your appetite changes
For the fastest results, its injectable form is especially appealing
Cardiovascular exercise enhances the fat-burning effects of both compounds